Harmony Biosciences Holdings (HRMY)
Debt-to-assets ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|
Long-term debt | US$ in thousands | 178,566 | 189,647 | 189,984 | 194,250 |
Total assets | US$ in thousands | 811,448 | 673,870 | 433,443 | 427,074 |
Debt-to-assets ratio | 0.22 | 0.28 | 0.44 | 0.45 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $178,566K ÷ $811,448K
= 0.22
The debt-to-assets ratio of Harmony Biosciences Holdings Inc has shown a declining trend over the past four years, indicating a strengthening financial position in terms of debt management and asset coverage. The ratio decreased from 0.45 in 2020 to 0.24 in 2023. This suggests that the company has been able to reduce its debt relative to its total assets over the period, which is generally viewed positively by investors and creditors. Lower debt-to-assets ratios indicate lower financial risk and a healthier balance sheet. It appears that Harmony Biosciences Holdings Inc has been effectively managing its debt levels in relation to its asset base, which is a positive signal for the company's overall financial health and stability.
Peer comparison
Dec 31, 2023